| 37932907 | Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy. | Ann Clin Transl Neurol | 2024 |
| 36798266 | Blocking muscle wasting via deletion of the muscle-specific E3 ubiquitin ligase MuRF1 impedes pancreatic tumor growth. | Res Sq | 2023 |
| 37325966 | Mechanisms of Skeletal Muscle Atrophy and Molecular Circuitry of Stem Cell Fate in Skeletal Muscle Regeneration and Aging. | J Gerontol A Biol Sci Med Sci | 2023 |
| 37202741 | The Antiparallel Coiled-Coil Domain Allows Multiple Forward Step Sizes of Myosin X. | J Phys Chem Lett | 2023 |
| 36995778 | Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy. | J Clin Invest | 2023 |
| 36240102 | Evaluating Genetic Modifiers of Duchenne Muscular Dystrophy Disease Progression Using Modeling and MRI. | Neurology | 2022 |
| 35681116 | Longitudinal changes in cardiac function in Duchenne muscular dystrophy population as measured by magnetic resonance imaging. | BMC Cardiovasc Disord | 2022 |
| 37206988 | Evaluation of the DBA/2J mouse as a potential background strain for genetic models of cardiomyopathy. | J Mol Cell Cardiol Plus | 2022 |
| 33394000 | Assessment of rAAVrh.74.MHCK7.micro-dystrophin Gene Therapy Using Magnetic Resonance Imaging in Children With Duchenne Muscular Dystrophy. | JAMA Netw Open | 2021 |
| 33678513 | Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trial. | Neuromuscul Disord | 2021 |
| 33762424 | Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel. | Open Heart | 2021 |
| 34519272 | Filopodia powered by class x myosin promote fusion of mammalian myoblasts. | Elife | 2021 |
| 34812732 | High-resolution structures of the actomyosin-V complex in three nucleotide states provide insights into the force generation mechanism. | Elife | 2021 |
| 34120912 | A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD Trial. | J Neuromuscul Dis | 2021 |
| 32286193 | Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort. | Radiology | 2020 |
| 32081426 | Simultaneous tracking of two motor domains reveals near simultaneous steps and stutter steps of myosin 10 on actin filament bundles. | Biochem Biophys Res Commun | 2020 |
| 32024675 | MR biomarkers predict clinical function in Duchenne muscular dystrophy. | Neurology | 2020 |
| 31689091 | Force Generation by Myosin Motors: A Structural Perspective. | Chem Rev | 2020 |
| 31830002 | Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle. | JCI Insight | 2020 |
| 31886717 | Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis. | Am J Physiol Heart Circ Physiol | 2020 |
| 32826942 | The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy. | Sci Rep | 2020 |
| 32184340 | Modeling disease trajectory in Duchenne muscular dystrophy. | Neurology | 2020 |
| 32451853 | Myosin Structures. | Adv Exp Med Biol | 2020 |
| 30452422 | Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy. | J Neuromuscul Dis | 2019 |
| 31323135 | Functional muscle hypertrophy by increased insulin-like growth factor 1 does not require dysferlin. | Muscle Nerve | 2019 |
| 30972202 | Smooth muscle atrophy and colon pathology in SMN deficient mice. | Am J Transl Res | 2019 |
| 29203356 | 226<sup>th</sup> ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands. | Neuromuscul Disord | 2018 |
| 29907980 | DMD genotype correlations from the Duchenne Registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype. | Hum Mutat | 2018 |
| 29928867 | Three-dimensional contractile muscle tissue consisting of human skeletal myocyte cell line. | Exp Cell Res | 2018 |
| 30141986 | Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery. | Am J Physiol Heart Circ Physiol | 2018 |
| 30222106 | Too much of a good thing. | Elife | 2018 |
| 29844196 | An intermediate along the recovery stroke of myosin VI revealed by X-ray crystallography and molecular dynamics. | Proc Natl Acad Sci U S A | 2018 |
| 30332629 | The Nuclear Receptor PPARγ Controls Progressive Macrophage Polarization as a Ligand-Insensitive Epigenomic Ratchet of Transcriptional Memory. | Immunity | 2018 |
| 29554116 | Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy. | PLoS One | 2018 |
| 29419405 | Muscle Contraction. | Cold Spring Harb Perspect Biol | 2018 |
| 29742798 | Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history. | Muscle Nerve | 2018 |
| 29716949 | Motor Proteins. | Cold Spring Harb Perspect Biol | 2018 |
| 29734234 | Two-Year Longitudinal Changes in Lower Limb Strength and Its Relation to Loss in Function in a Large Cohort of Patients With Duchenne Muscular Dystrophy. | Am J Phys Med Rehabil | 2018 |
| 29365354 | Leg muscle MRI in identical twin boys with duchenne muscular dystrophy. | Muscle Nerve | 2018 |
| 27879251 | Altered Smooth Muscle Cell Force Generation as a Driver of Thoracic Aortic Aneurysms and Dissections. | Arterioscler Thromb Vasc Biol | 2017 |
| 28228973 | Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy. | PLoS Curr | 2017 |
| 28270449 | Supraphysiological levels of GDF11 induce striated muscle atrophy. | EMBO Mol Med | 2017 |
| 28972192 | A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy. | Neurology | 2017 |
| 28728956 | Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. | Lancet | 2017 |
| 26891991 | Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort. | Ann Neurol | 2016 |
| 26616495 | Increased collagen cross-linking is a signature of dystrophin-deficient muscle. | Muscle Nerve | 2016 |
| 28018975 | Disease-modifying effects of orally bioavailable NF-<b>κ</b>B inhibitors in dystrophin-deficient muscle. | JCI Insight | 2016 |
| 27870893 | Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy. | PLoS One | 2016 |
| 27580874 | The myosin X motor is optimized for movement on actin bundles. | Nat Commun | 2016 |
| 27717739 | How Myosin Generates Force on Actin Filaments. | Trends Biochem Sci | 2016 |